LC-MS/MS determination of trazodone in human plasma and its pharmacokinetic study in healthy Chinese
- PMID: 40371913
- PMCID: PMC12160597
- DOI: 10.1080/17576180.2025.2506349
LC-MS/MS determination of trazodone in human plasma and its pharmacokinetic study in healthy Chinese
Abstract
Aims: This study aimed to establish a robust LC-MS/MS method for quantifying trazodone in human plasma and investigate its pharmacokinetic profile in healthy Chinese subjects under fasting and fed conditions.
Materials & methods: A validated LC-MS/MS method using protein precipitation was applied to analyze trazodone in 68 healthy subjects (34 fasting/34 fed), with full method validation performed.
Results: This method exhibited high selectivity, precision, and accuracy. The results showed good linearity in the range of 5-3000 ng/mL and matrix effect results showed no matrix interference. The pharmacokinetic data revealed notable differences between the fasting and postprandial states.
Conclusions: The validated LC-MS/MS method proved reliable for trazodone quantification. The observed food effects on absorption suggest clinical dosing should consider administration conditions to ensure optimal therapeutic outcomes.
Keywords: LC-MS/MS; Trazodone hydrochloride; internal standard; isotopic trazodone-d6; methodology validation; pharmacokinetic.
Plain language summary
Trazodone hydrochloride is a medicine used to treat depression and sleep problems. To understand how the body processes this drug, we developed a method to measure how much trazodone is in the blood after taking it. We tested this method on healthy adults who took the medicine either with food or on an empty stomach. Our study found that eating before taking trazodone slows down how quickly the drug is absorbed, but does not change the total amount the body receives. No serious side effects were observed. This information helps doctors decide the best way for patients to take trazodone and shows that our testing method works well for future medical studies.
Conflict of interest statement
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.
Similar articles
-
Pharmacokinetic study of isavuconazonium in human plasma measured by HPLC-MS/MS and its use in healthy Chinese subjects.Bioanalysis. 2025 Aug;17(16):1031-1039. doi: 10.1080/17576180.2025.2548195. Epub 2025 Aug 19. Bioanalysis. 2025. PMID: 40827693
-
Pharmacotherapies for sleep disturbances in dementia.Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2020 Nov 15;11:CD009178. doi: 10.1002/14651858.CD009178.pub4. PMID: 27851868 Free PMC article. Updated.
-
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948. Health Technol Assess. 2024. PMID: 39367772 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
References
-
- Tao W, Duan J, Guo J, et al. Simultaneous determination of triterpenoid saponins in dog plasma by a validated UPLC–MS/MS and its application to a pharmacokinetic study after administration of total saponin of licorice. J Pharm Biomed Anal. 2013;75:248–255. doi: 10.1016/j.jpba.2012.11.035 - DOI - PubMed
-
•• This paper constructs and validates an UPLC-MS/MS method, which has important reference value for the methodological construction and pharmacokinetic exploration of similar studies.
-
- Karhu D, Gossen ER, Mostert A, et al. Safety, tolerability, and pharmacokinetics of once-daily trazodone extended-release caplets in healthy subjects. Int J Clin Pharmacol Ther. 2011;49(12):730–743. doi: 10.5414/CP201546 - DOI - PubMed
-
• This literature was conducted in healthy subjects, and these key data provide a solid basis for the rational use of this drug in clinical treatment.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources